Analyst firms · Barclays · QURE

Barclays QURE price target and rating history

uniQure N.V. (QURE) · Health Care

Barclays rates uniQure N.V. (QURE) Equal Weight with a $28 price target, as of its latest action on Oct 5, 2026. It has published 3 rating actions on QURE since January 2026, including 1 upgrade and 1 downgrade. Across 6 firms with a QURE price target in the last 12 months, the median target is $47.50. Barclays's $28 is 41% below that.

Current rating
Equal Weight
Price target
$28
Median target, all firms
$47.50
Actions on QURE
3

Barclays price target on QURE

$65$47$28
Barclays price target on QURE, each point a stated target, January 2026 to October 2026.

Every Barclays rating on QURE

How other firms rate QURE

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BarclaysEqual Weight$28Oct 5, 2026
William BlairOutperformSep 2, 2026
Wolfe ResearchOutperform$65Jul 30, 2026
Cantor FitzgeraldOverweight$61Jun 17, 2026
MizuhoOutperform$35Mar 11, 2026
RBC Capital MarketsOutperform$35Mar 9, 2026
Wells FargoOverweight$60Mar 9, 2026

Questions about Barclays and QURE

What is Barclays's price target for QURE?
Barclays's latest stated price target for uniQure N.V. (QURE) is $28, from its action on Oct 5, 2026.
What is Barclays's rating on QURE?
Barclays rates QURE Equal Weight, a neutral rating, as of Oct 5, 2026.
When did Barclays last change its view on QURE?
On Oct 5, 2026, Barclays downgrades to Equal Weight from Overweight, price target $28.
How does Barclays's QURE target compare with other analysts?
Across 6 firms with a QURE price target in the last 12 months, the median target is $47.50. Barclays's $28 is 41% below that.

More QURE rating histories

All Barclays ratingsQURE news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.